The Clinical Trials Transformation Initiative (CTTI) is a public-private partnership to identify practices that will increase the quality and efficiency of clinical trials. CTTI now comprises more than 60 organizations from across the clinical trial enterprise. Members include representatives of government agencies (the FDA, Centers for Medicare and Medicaid Services, Office of Human Research Protections, National Institutes of Health, and other national and international governmental bodies), industry representatives (pharmaceutical, biotech, device, and clinical research organizations), patient advocacy groups, professional societies, investigator groups, academic institutions, and other interested parties. CTTI is funded by the Food and Drug Administration and coordinated by Duke University.
The Feinstein Institute for Medical Research has been a member since 2010. Northwell Health participates on various CTTI initiatives including projects aimed at improving administration and regulation of clinical research.
For more information, please visit the CTTI webpage.